The risk or severity of adverse effects can be increased when amobarbital is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when alprazolam is combined with ketamine.


The risk or severity of adverse effects can be increased when cisplatin is combined with vinorelbine.


The risk or severity of adverse effects can be increased when cisplatin is combined with clozapine.


The risk or severity of adverse effects can be increased when fenbufen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with sertraline.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when maprotiline is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when triazolam is combined with zopiclone.


The risk or severity of adverse effects can be increased when flunarizine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ramipril is combined with resveratrol.


The risk or severity of adverse effects can be increased when triazolam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when prednisone is combined with donepezil.


The risk or severity of adverse effects can be increased when Trospium is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with butamben.


The risk or severity of adverse effects can be increased when procaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when morphine is combined with scopolamine.


The risk or severity of adverse effects can be increased when pramipexole is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when procaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when pramipexole is combined with quinapril.


The risk or severity of adverse effects can be increased when pramipexole is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amisulpride is combined with scopolamine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when tolterodine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ketamine is combined with clidinium.


The risk or severity of adverse effects can be increased when citalopram is combined with periciazine.


The risk or severity of adverse effects can be increased when dyclonine is combined with scopolamine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with zotepine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with enoxacin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ramipril is combined with methazolamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with ketamine.


The risk or severity of adverse effects can be increased when quazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with tretinoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when physostigmine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when phentolamine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when propantheline is combined with topiramate.


The risk or severity of adverse effects can be increased when gabapentin is combined with tiapride.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with paroxetine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Lapatinib.


The risk or severity of adverse effects can be increased when pentazocine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when cilazapril is combined with indomethacin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Metixene.


The risk or severity of adverse effects can be increased when oxazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with butamben.


The risk or severity of adverse effects can be increased when sertraline is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with quetiapine.


The risk or severity of adverse effects can be increased when propofol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when propofol is combined with tolazoline.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with quetiapine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with ketamine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with simvastatin.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with thiothixene.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nystatin is combined with nicardipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with proparacaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with meclizine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with nadolol.


The risk or severity of adverse effects can be increased when benazepril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with donepezil.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when bumetanide is combined with cilazapril.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when bepridil is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with duloxetine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with betaxolol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ketorolac is combined with betamethasone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with buprenorphine.


The risk or severity of adverse effects can be increased when clozapine is combined with prazosin.


The risk or severity of adverse effects can be increased when dantrolene is combined with sertraline.


The risk or severity of adverse effects can be increased when leflunomide is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when promazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when clomipramine is combined with phentolamine.


The risk or severity of adverse effects can be increased when clomipramine is combined with furosemide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Articaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Agomelatine.


The risk or severity of adverse effects can be increased when antipyrine is combined with medrysone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when barnidipine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when barnidipine is combined with metolazone.


The risk or severity of adverse effects can be increased when dibucaine is combined with prazepam.


The risk or severity of adverse effects can be increased when phentolamine is combined with terazosin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with metolazone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when dibucaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with felodipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when trimeprazine is combined with citalopram.


The risk or severity of adverse effects can be increased when butabarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with zaleplon.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with paramethasone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with budesonide.


The risk or severity of adverse effects can be increased when dyclonine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with methyldopa.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when barnidipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with morphine.


The risk or severity of adverse effects can be increased when diclofenac is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when xylometazoline is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Torasemide is combined with fosinopril.


The risk or severity of adverse effects can be increased when codeine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when xylometazoline is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Prasugrel is combined with aspirin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when clorazepate is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when clorazepate is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when betaxolol is combined with losartan.


The risk or severity of adverse effects can be increased when Asenapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with fluocinonide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with indapamide.


The risk or severity of adverse effects can be increased when amiodarone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when etodolac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when alclofenac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when amiodarone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when alclofenac is combined with paramethasone.


The risk or severity of adverse effects can be increased when temazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when etodolac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when diltiazem is combined with acebutolol.


The risk or severity of adverse effects can be increased when gabapentin is combined with butalbital.


The risk or severity of adverse effects can be increased when Trospium is combined with levorphanol.


The risk or severity of adverse effects can be increased when enflurane is combined with METAXALONE.


The risk or severity of adverse effects can be increased when methadone is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when estazolam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when gabapentin is combined with Retigabine.


The risk or severity of adverse effects can be increased when procyclidine is combined with pentazocine.


The risk or severity of adverse effects can be increased when meperidine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when meperidine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when meperidine is combined with benzocaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with atenolol.


The risk or severity of adverse effects can be increased when quinapril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when quinapril is combined with methyldopa.


The risk or severity of adverse effects can be increased when thiamylal is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Nebivolol is combined with nicotine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with hydralazine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with HEROIN.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when lidocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with lithium ion.


The risk or severity of adverse effects can be increased when methylene blue is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Tramadol is combined with Melatonin.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with decamethonium.


The risk or severity of adverse effects can be increased when Tramadol is combined with brotizolam.


The risk or severity of adverse effects can be increased when nicergoline is combined with Idelalisib.


The risk or severity of adverse effects can be increased when nilvadipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with ethotoin.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Riociguat.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when nilvadipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when quinapril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with nalbuphine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when etodolac is combined with Icatibant.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with butamben.


The risk or severity of adverse effects can be increased when Rufinamide is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with flunarizine.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when meclizine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with epirizole.


The risk or severity of adverse effects can be increased when cetirizine is combined with scopolamine.


The risk or severity of adverse effects can be increased when bumetanide is combined with amikacin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when thiopental is combined with Articaine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with tiapride.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with butalbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with clonazepam.


The risk or severity of adverse effects can be increased when trimipramine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when milrinone is combined with Apixaban.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with fenbufen.


The risk or severity of adverse effects can be increased when pentazocine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when baclofen is combined with Iloperidone.


The risk or severity of adverse effects can be increased when quetiapine is combined with Asenapine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with dopamine.


The risk or severity of adverse effects can be increased when quazepam is combined with procaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with trimipramine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with thiopental.


The risk or severity of adverse effects can be increased when zopiclone is combined with procaine.


The risk or severity of adverse effects can be increased when azelastine is combined with estrone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with primidone.


The risk or severity of adverse effects can be increased when codeine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Nepafenac.


The risk or severity of adverse effects can be increased when oxprenolol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when metaraminol is combined with epinephrine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when morphine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with Fondaparinux.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with thioridazine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with losartan.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when alprazolam is combined with diazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with propoxyphene.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with dyclonine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with estrone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Conivaptan.


The risk or severity of adverse effects can be increased when cerulenin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with DEXKETOPROFEN.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with clemastine.


The risk or severity of adverse effects can be increased when dyclonine is combined with butamben.


The risk or severity of adverse effects can be increased when Olaparib is combined with clozapine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when loxapine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with clidinium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with mepivacaine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when pentazocine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with zaleplon.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Desloratadine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Perospirone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when fexofenadine is combined with duloxetine.


The risk or severity of adverse effects can be increased when enalapril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when fexofenadine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when enalapril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when morniflumate is combined with nimesulide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Propiverine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with isradipine.


The risk or severity of adverse effects can be increased when Articaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with paroxetine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when tizanidine is combined with primidone.


The risk or severity of adverse effects can be increased when isradipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Perospirone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Melatonin is combined with dantrolene.


The risk or severity of adverse effects can be increased when olanzapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Perospirone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when selegiline is combined with domperidone.


The risk or severity of adverse effects can be increased when Halazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with butorphanol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Etidocaine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with flunarizine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with zotepine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when prazosin is combined with felodipine.


The risk or severity of adverse effects can be increased when prazosin is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when mesalamine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with triprolidine.


The risk or severity of adverse effects can be increased when enflurane is combined with Pizotifen.


The risk or severity of adverse effects can be increased when mesalamine is combined with paramethasone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with methylphenidate.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with methocarbamol.


The risk or severity of adverse effects can be increased when isradipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Droxicam.


The risk or severity of adverse effects can be increased when Butethal is combined with meclizine.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when metoclopramide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with etizolam.


The risk or severity of adverse effects can be increased when methocarbamol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when butorphanol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with alclofenac.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when trazodone is combined with maprotiline.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with methylene blue.


The risk or severity of adverse effects can be increased when clemastine is combined with oxycodone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Alvimopan.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with felodipine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nisoldipine.


The risk or severity of adverse effects can be increased when promazine is combined with procaine.


The risk or severity of adverse effects can be increased when Triflusal is combined with salicylic acid.


The risk or severity of adverse effects can be increased when sulpiride is combined with Pramocaine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with brimonidine.


The risk or severity of adverse effects can be increased when diazepam is combined with gabapentin.


The risk or severity of adverse effects can be increased when carprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when citric acid is combined with Nintedanib.


The risk or severity of adverse effects can be increased when Remoxipride is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Nabilone is combined with felodipine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with enflurane.


The risk or severity of adverse effects can be increased when Ephedrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when desipramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when furazolidone is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when loratadine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with irbesartan.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with tretinoin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with isoflurane.


The risk or severity of adverse effects can be increased when duloxetine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with clidinium.


The risk or severity of adverse effects can be increased when nefazodone is combined with rasagiline.


The risk or severity of adverse effects can be increased when Vardenafil is combined with Udenafil.


The risk or severity of adverse effects can be increased when alprazolam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when acebutolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with scopolamine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when irbesartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when bromocriptine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when tropicamide is combined with buprenorphine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when meprobamate is combined with triazolam.


The risk or severity of adverse effects can be increased when epirizole is combined with flunisolide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when buspirone is combined with doxepin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with Riociguat.


The risk or severity of adverse effects can be increased when meprobamate is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when labetalol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Droxicam.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when betaxolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Flibanserin is combined with sertraline.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with minoxidil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Treprostinil is combined with suprofen.


The risk or severity of adverse effects can be increased when methysergide is combined with felodipine.


The risk or severity of adverse effects can be increased when linezolid is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with chlormezanone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Apremilast.


The risk or severity of adverse effects can be increased when barnidipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when lorazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when antipyrine is combined with prilocaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with quinapril.


The risk or severity of adverse effects can be increased when barnidipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when efavirenz is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when tiagabine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when selegiline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when levorphanol is combined with Toloxatone.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pirlindole.


The risk or severity of adverse effects can be increased when imipramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Carbetocin is combined with valsartan.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ILOPROST.


The risk or severity of adverse effects can be increased when Arotinolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with phenytoin.


The risk or severity of adverse effects can be increased when Naftifine is combined with manidipine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when prednisone is combined with decamethonium.


The risk or severity of adverse effects can be increased when nabumetone is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when proparacaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Naftifine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when naratriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when butabarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Melatonin.


The risk or severity of adverse effects can be increased when methocarbamol is combined with primidone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with clonazepam.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with pentazocine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with mecamylamine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with loratadine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Salbutamol.


The risk or severity of adverse effects can be increased when mesalamine is combined with acemetacin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with tioconazole.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with felbamate.


The risk or severity of adverse effects can be increased when cilazapril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with clemastine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when levorphanol is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Propacetamol is combined with prednisone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ramipril.


The risk or severity of adverse effects can be increased when Propacetamol is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when methylergonovine is combined with methimazole.


The risk or severity of adverse effects can be increased when methylergonovine is combined with irinotecan.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with valsartan.


The risk or severity of adverse effects can be increased when METAXALONE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with brotizolam.


The risk or severity of adverse effects can be increased when pimozide is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when metoprolol is combined with triamterene.


The risk or severity of adverse effects can be increased when trazodone is combined with tizanidine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Agomelatine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Perospirone.


The risk or severity of adverse effects can be increased when leflunomide is combined with equilin.


The risk or severity of adverse effects can be increased when clozapine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when zaleplon is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when zaleplon is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with aspirin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when difluprednate is combined with ambenonium.


The risk or severity of adverse effects can be increased when procaine is combined with levodopa.


The risk or severity of adverse effects can be increased when rapamycin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when HEROIN is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when reserpine is combined with Asenapine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when rapamycin is combined with Spirapril.


The risk or severity of adverse effects can be increased when procaine is combined with baclofen.


The risk or severity of adverse effects can be increased when cilostazol is combined with aspirin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when phenobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when perphenazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Butethal is combined with dantrolene.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when rasagiline is combined with loxapine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Remoxipride.


The risk or severity of adverse effects can be increased when thiothixene is combined with benzocaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when thiothixene is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when LISURIDE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when procaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when pravastatin is combined with paroxetine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with methylergonovine.


The risk or severity of adverse effects can be increased when procaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when fluocinonide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ropinirole.


The risk or severity of adverse effects can be increased when butabarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when procaine is combined with prazepam.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when LISURIDE is combined with mefloquine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with meclizine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when oxycodone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with glutethimide.


The risk or severity of adverse effects can be increased when pramipexole is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with clemastine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Butethal.


The risk or severity of adverse effects can be increased when pancuronium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Rotigotine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with ritodrine.


The risk or severity of adverse effects can be increased when atenolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when paroxetine is combined with doxepin.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when proparacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with hydralazine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with protriptyline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with nabumetone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with cetirizine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Icatibant is combined with betamethasone.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when PAMIDRONIC ACID is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with amisulpride.


The risk or severity of adverse effects can be increased when cilnidipine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when flunarizine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when leflunomide is combined with Tixocortol.


The risk or severity of adverse effects can be increased when protriptyline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Normethadone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when bumetanide is combined with gentamicin.


The risk or severity of adverse effects can be increased when Normethadone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Tapentadol.


The risk or severity of adverse effects can be increased when amoxapine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when propranolol is combined with nadolol.


The risk or severity of adverse effects can be increased when amoxapine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when cinnarizine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when thiothixene is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when glutethimide is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with felodipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with sulpiride.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with methadone.


The risk or severity of adverse effects can be increased when tizanidine is combined with Retigabine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with spironolactone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with propranolol.


The risk or severity of adverse effects can be increased when DESONIDE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with sertraline.


The risk or severity of adverse effects can be increased when procyclidine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Vilazodone is combined with pimozide.


The risk or severity of adverse effects can be increased when triamterene is combined with captopril.


The risk or severity of adverse effects can be increased when methadone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when bepridil is combined with papaverine.


The risk or severity of adverse effects can be increased when nicergoline is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Lurasidone is combined with dantrolene.


The risk or severity of adverse effects can be increased when butorphanol is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when ketamine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with enalapril.


The risk or severity of adverse effects can be increased when clorazepate is combined with trazodone.


The risk or severity of adverse effects can be increased when estazolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when sulpiride is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Clofarabine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when propofol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when amiodarone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when floctafenine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when barnidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when zaleplon is combined with ethotoin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with butalbital.


The risk or severity of adverse effects can be increased when Trametinib is combined with Dabrafenib.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Deferasirox.


The risk or severity of adverse effects can be increased when dibucaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when carprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when lidocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when melphalan is combined with clozapine.


The risk or severity of adverse effects can be increased when doxylamine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when levorphanol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when brotizolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when diclofenac is combined with Mometasone.


The risk or severity of adverse effects can be increased when brotizolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when apomorphine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when apomorphine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when bromazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when bepridil is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when acemetacin is combined with Halobetasol.


The risk or severity of adverse effects can be increased when acemetacin is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when flunisolide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Sunitinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when risperidone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with estrone.


The risk or severity of adverse effects can be increased when diclofenac is combined with formestane.


The risk or severity of adverse effects can be increased when salicylamide is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when procyclidine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when irbesartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with thiamylal.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiamylal is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with penbutolol.


The risk or severity of adverse effects can be increased when temazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when halothane is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Etomidate is combined with efavirenz.


The risk or severity of adverse effects can be increased when Cangrelor is combined with diflunisal.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when doxepin is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when olanzapine is combined with propofol.


The risk or severity of adverse effects can be increased when tizanidine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Olmesartan is combined with metolazone.


The risk or severity of adverse effects can be increased when doxepin is combined with isoproterenol.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when secobarbital is combined with Paliperidone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Lenalidomide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with papaverine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with tiapride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Perospirone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when reserpine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when hydromorphone is combined with tiapride.


The risk or severity of adverse effects can be increased when cocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when doxazosin is combined with methyldopa.


The risk or severity of adverse effects can be increased when secobarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nitrendipine.


The risk or severity of adverse effects can be increased when tizanidine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clomipramine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when oxazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when docetaxel is combined with RUCAPARIB.


The risk or severity of adverse effects can be increased when metoprolol is combined with isradipine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when diclofenac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when metoprolol is combined with Olmesartan.


The risk or severity of adverse effects can be increased when glutethimide is combined with efavirenz.


The risk or severity of adverse effects can be increased when fenbufen is combined with epirizole.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triazolam is combined with bromazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with mepivacaine.


The risk or severity of adverse effects can be increased when salicylamide is combined with budesonide.


The risk or severity of adverse effects can be increased when propantheline is combined with nalbuphine.


The risk or severity of adverse effects can be increased when loxapine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when cilazapril is combined with azelastine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Trospium is combined with tolterodine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Icatibant.


The risk or severity of adverse effects can be increased when azelastine is combined with flunisolide.


The risk or severity of adverse effects can be increased when loxapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when triprolidine is combined with primidone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when valsartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when citalopram is combined with reserpine.


The risk or severity of adverse effects can be increased when loxapine is combined with enflurane.


The risk or severity of adverse effects can be increased when triazolam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when triazolam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when ketoprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when sotalol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Agomelatine is combined with meclizine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Tianeptine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Articaine.


The risk or severity of adverse effects can be increased when 5-azacytidine is combined with clozapine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Benidipine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Retigabine.


The risk or severity of adverse effects can be increased when metolazone is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when trimipramine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when bifonazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with alclofenac.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when cabergoline is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when haloprogin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when itraconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when pentazocine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Flupentixol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ramipril.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when rasagiline is combined with terbutaline.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when pergolide is combined with loratadine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when quetiapine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Halobetasol.


The risk or severity of adverse effects can be increased when flurazepam is combined with risperidone.


The risk or severity of adverse effects can be increased when pergolide is combined with clindamycin.


The risk or severity of adverse effects can be increased when flurazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when betaxolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when betaxolol is combined with quinapril.


The risk or severity of adverse effects can be increased when proparacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when betaxolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when trimeprazine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Halazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with oxprenolol.


The risk or severity of adverse effects can be increased when proparacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with efavirenz.


The risk or severity of adverse effects can be increased when indapamide is combined with hydralazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when secobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when thioridazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ethotoin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with loratadine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with imipramine.


The risk or severity of adverse effects can be increased when amisulpride is combined with brotizolam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Difenoxin.


The risk or severity of adverse effects can be increased when pentamidine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Agomelatine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cetirizine is combined with Retigabine.


The risk or severity of adverse effects can be increased when butabarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with nalbuphine.


The risk or severity of adverse effects can be increased when butabarbital is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when ramipril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when prazosin is combined with quetiapine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with imipramine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Riociguat.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with loratadine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when triazolam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with amcinonide.


The risk or severity of adverse effects can be increased when moclobemide is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with diltiazem.


The risk or severity of adverse effects can be increased when isoflurane is combined with cetirizine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with primidone.


The risk or severity of adverse effects can be increased when isoflurane is combined with protriptyline.


The risk or severity of adverse effects can be increased when triprolidine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when isradipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when biperiden is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with thiothixene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tetracaine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when trazodone is combined with zonisamide.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with triprolidine.


The risk or severity of adverse effects can be increased when pimozide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when mesalamine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when ketorolac is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Pentolinium is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when quinapril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when quinapril is combined with etodolac.


The risk or severity of adverse effects can be increased when tenoxicam is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when propranolol is combined with nicardipine.


The risk or severity of adverse effects can be increased when Halazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with triamterene.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with butalbital.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Articaine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with tiapride.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with cetirizine.


The risk or severity of adverse effects can be increased when clonidine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with duloxetine.


The risk or severity of adverse effects can be increased when halcinonide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when halcinonide is combined with galanthamine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Normethadone.


The risk or severity of adverse effects can be increased when Articaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when oxybutynin is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when ethopropazine is combined with methadone.


The risk or severity of adverse effects can be increased when barnidipine is combined with halothane.


The risk or severity of adverse effects can be increased when estazolam is combined with tiapride.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with efavirenz.


The risk or severity of adverse effects can be increased when Butoconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Tofacitinib.


The risk or severity of adverse effects can be increased when pergolide is combined with manidipine.


The risk or severity of adverse effects can be increased when imipramine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when tretinoin is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with clonidine.


The risk or severity of adverse effects can be increased when tretinoin is combined with quinapril.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when tretinoin is combined with bumetanide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when dibucaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when dibucaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when morphine is combined with quazepam.


The risk or severity of adverse effects can be increased when propofol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with doxepin.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Normethadone.


The risk or severity of adverse effects can be increased when ondansetron is combined with zonisamide.


The risk or severity of adverse effects can be increased when Tapentadol is combined with methazolamide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with captopril.


The risk or severity of adverse effects can be increased when barnidipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when amobarbital is combined with Etomidate.


The risk or severity of adverse effects can be increased when propofol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with acebutolol.


The risk or severity of adverse effects can be increased when loratadine is combined with promethazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when amobarbital is combined with bupivacaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with dipyridamole.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with desipramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with sertraline.


The risk or severity of adverse effects can be increased when celiprolol is combined with nylidrin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with furosemide.


The risk or severity of adverse effects can be increased when Desloratadine is combined with paroxetine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with tizanidine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with baclofen.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with halcinonide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ondansetron.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with levodopa.


The risk or severity of adverse effects can be increased when Salsalate is combined with Clobetasone.


The risk or severity of adverse effects can be increased when perphenazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with zonisamide.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when nalbuphine is combined with primidone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with DESONIDE.


The risk or severity of adverse effects can be increased when bromazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when tetrahydrozoline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with propranolol.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when clonazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when bromazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when gabapentin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with prazepam.


The risk or severity of adverse effects can be increased when methysergide is combined with Idelalisib.


The risk or severity of adverse effects can be increased when buspirone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with loratadine.


The risk or severity of adverse effects can be increased when dyclonine is combined with prazepam.


The risk or severity of adverse effects can be increased when clomipramine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with nilvadipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with cocaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when labetalol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when tretinoin is combined with metoprolol.


The risk or severity of adverse effects can be increased when eperisone is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with sertraline.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with prilocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with ethotoin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when diazepam is combined with zaleplon.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with oxycodone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Melatonin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Propiverine.


The risk or severity of adverse effects can be increased when furazolidone is combined with Salbutamol.


The risk or severity of adverse effects can be increased when carprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Propacetamol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with promethazine.


The risk or severity of adverse effects can be increased when barnidipine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with triprolidine.


The risk or severity of adverse effects can be increased when enflurane is combined with phenytoin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with antipyrine.


The risk or severity of adverse effects can be increased when propofol is combined with atenolol.


The risk or severity of adverse effects can be increased when nimesulide is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when benzocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when timolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when prazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Pentolinium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when thiamylal is combined with tetracaine.


The risk or severity of adverse effects can be increased when propofol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when loteprednol is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with histamine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when celecoxib is combined with betamethasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with butamben.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Flibanserin.


The risk or severity of adverse effects can be increased when propranolol is combined with irbesartan.


The risk or severity of adverse effects can be increased when cinnarizine is combined with simvastatin.


The risk or severity of adverse effects can be increased when propranolol is combined with felodipine.


The risk or severity of adverse effects can be increased when propranolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trimipramine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Normethadone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with bupropion.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Gabapentin enacarbil.